Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Current Leases (2017 - 2025)

Jaguar Health (JAGX) has disclosed Current Leases for 9 consecutive years, with $226000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Current Leases fell 38.59% to $226000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $226000.0, a 38.59% decrease, with the full-year FY2024 number at $299000.0, down 14.08% from a year prior.
  • Current Leases was $226000.0 for Q3 2025 at Jaguar Health, down from $256000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $526000.0 in Q3 2023 to a low of $199000.0 in Q2 2021.
  • A 5-year average of $362500.0 and a median of $358000.0 in 2023 define the central range for Current Leases.
  • Peak YoY movement for Current Leases: surged 101.25% in 2022, then plummeted 41.79% in 2025.
  • Jaguar Health's Current Leases stood at $240000.0 in 2021, then surged by 101.25% to $483000.0 in 2022, then dropped by 27.95% to $348000.0 in 2023, then fell by 14.08% to $299000.0 in 2024, then dropped by 24.41% to $226000.0 in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Current Leases are $226000.0 (Q3 2025), $256000.0 (Q2 2025), and $273000.0 (Q1 2025).